Regulation by CRAMP of the responses of murine peritoneal macrophages to extracellular ATP

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 3, 2010, Pages 569-578

  Seil, Michèle ^a   Kabré, Elie ^b   Nagant, Carole ^a   Vandenbranden, Michel ^c   Fontanils, Unai ^d   Marino, Aida ^d   Pochet, Stéphanie ^a   Dehaye, Jean Paul ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^c Faculty of Sciences CP 206/02   (Belgium)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Antimicrobial peptide; Ivermectin; P2X7 KO mice; Purinergic receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; ETHIDIUM BROMIDE; GLYCYLLEUCYLLEUCYLARGINYLLYSYLGLYCYLGLYCYLGLUTAMYLLYSYLISOLEUCYLGLYCYLGLUTAMYLLYSYLLEUCYLLYSYLLYSYLISOLEUCYLGLYCYLGLUTAMINYLLYSYLISOLEUCYLLYSYLASPARAGINYLPHENYLALANYLPHENYLALANYLGLYCYLLYSYLLEUCYLVALYLPROLYLGLUTAMINYLPROLYLGLUTAMYLGLUTAMINE; INTERLEUKIN 1BETA; IVERMECTIN; LACTATE DEHYDROGENASE; OLEIC ACID; POLYPEPTIDE ANTIBIOTIC AGENT; POTASSIUM ION; PURINERGIC P2X4 RECEPTOR; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ALLOSTERISM; ALPHA HELIX; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEUM; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; REGULATORY MECHANISM; STRUCTURE ANALYSIS;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CATHELICIDINS; ETHIDIUM; EXTRACELLULAR SPACE; INTERLEUKIN-1BETA; ION CHANNEL GATING; ION CHANNELS; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; OLEIC ACID; POTASSIUM; PROTEIN STRUCTURE, SECONDARY; REACTIVE OXYGEN SPECIES; RECEPTORS, FORMYL PEPTIDE; SPECTROPHOTOMETRY, INFRARED;

MURINAE; MUS;

EID: 76749149194     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.11.002     Document Type: Article

References (42)

1. Zasloff M. Antimicrobial peptides in health and disease. N. Engl. J. Med. 347 (2002) 1199-1200
2. Zanetti M., Gennaro R., and Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374 (1995) 1-5
3. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75 (2004) 39-48
4. Gudmundsson G.H., Agerberth B., Odeberg J., Bergman T., Olsson B., and Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238 (1996) 325-332
5. Johansson J., Gudmundsson G.H., Rottenberg M.E., Berndt K.D., and Agerberth B. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 273 (1998) 3718-3724
6. Travis S.M., Anderson N.N., Forsyth W.R., Espiritu C., Conway B.D., Greenberg E.P., McCray P.B., Lehrer R.I., Welsh M.J., and Tack B.F. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect. Immun. 68 (2000) 2748-2755
7. Golec M. Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide. Ann. Agric. Environ. Med. 14 (2007) 1-4
8. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jörnvall H., Wigzell H., and Gudmundsson G.H. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96 (2000) 3086-3093
9. Heilborn J.D., Nilsson M.F., Kratz G., Weber G., Sørensen O., Borregaard N., and Ståhle-Bäckdahl M. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120 (2003) 379-389
10. Koczulla R., von Degenfeld G., Kupatt C., Krötz F., Zahler S., Gloe T., Issbrücker K., Unterberger P., Zaiou M., Lebherz C., Karl A., Raake P., Pfosser A., Boekstegers P., Welsch U., Hiemstra P.S., Vogelmeier C., Gallo R.L., Clauss M., and Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111 (2003) 1665-1672
11. Gough M., Hancock R.E., and Kelly N.M. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect. Immun. 64 (1996) 4922-4927
12. Kandler K., Shaykhiev R., Kleemann P., Klescz F., Lohoff M., Vogelmeier C., and Bals R. The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int. Immunol. 18 (2006) 1729-1736
13. Tjabringa G.S., Aarbiou J., Ninaber D.K., Drijfhout J.W., Sørensen O.E., Borregaard N., Rabe K.F., and Hiemstra P.S. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 171 (2003) 6690-6696
14. Le Y., Yang Y., Cui Y., Yazawa H., Gong W., Qiu C., and Wang J.M. Receptors for chemotactic formyl peptides as pharmacological targets. Int. Immunopharmacol. 2 (2002) 1-13
15. Mookherjee N., Lippert D.N.D., Hamill P., Falsafi R., Nijnik A., Kindrachuk J., Pistolic J., Gardy J., Miri P., Naseer M., Foster L.J., and Hancock R.E.W. Intracellular receptor for human host defense peptide LL-37 in monocytes. J. Immunol. 183 (2009) 2688-2696
16. Elssner A., Duncan M., Gavrilin M., Wewers M.D., and novel P2X7 receptor activator A. the human cathelicidin-derived peptide LL-37, induces IL-1 beta processing and release. J. Immunol. 72 (2004) 4987-4994
17. Pochet S., Tandel S., Querriére S., Tre-Hardy M., Garcia-Marcos M., De Lorenzi M., Vandenbranden M., Marino A., Devleeschouwer M., and Dehaye J.P. Modulation by LL-37 of the responses of salivary glands to purinergic agonists. Mol. Pharmacol. 69 (2006) 2037-2046
18. Gallo R.L., Kim K.J., Bernfield M., Kozak C.A., Zanetti M., Merluzzi L., and Gennaro R. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J. Biol. Chem. 272 (1997) 13088-13093
19. Pochet S., Garcia-Marcos M., Seil M., Otto A., Marino A., and Dehaye J.P. Contribution of two ionotropic purinergic receptors to ATP responses in submandibular gland ductal cells. Cell. Signal. 19 (2007) 2155-2164
20. McCarron R.M., Goroff D.K., Luhr J.E., Murphy M.A., and Herscowitz H.B. Methods for the collection of peritoneal and alveolar macrophages. Methods Enzymol 108 (1984) 274-284
21. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985) 3440-3450
22. 7 agonist or to maitotoxin. Cell. Signal. 13 (2001) 465-473
23. 7 receptors in mouse submandibular glands. Purinergic Signal. 4 (2008) 347-355
24. Vigano C., Manciu L., Buyse F., Goormaghtigh E., and Ruysschaert J.M. Attenuated total reflection IR spectroscopy as a tool to investigate the structure, orientation and tertiary structure changes in peptides and membrane proteins. Biopolymers 55 (2000) 373-380
25. Goormaghtigh E., Ruysschaert J.M., and Raussens V. Evaluation of the information content in infrared spectra for protein secondary structure determination. Biophys. J. 89 (2006) 2946-2957
26. Coutinho-Silva R., Ojcius D.M., Gorecki D.C., Persechini P.M., Bisaggio R.C., Mendes A.N., Marks J., Burnstock G., and Dunn P.M. Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages. Biochem. Pharmacol. 69 (2005) 641-655
27. 4 receptors reveal a novel mechanism of ligand-gated channel facilitation by ivermectin. Mol. Pharmacol. 69 (2006) 576-587
28. Kurosaka K., Chen Q., Yarovinsky F., Oppenheim J.J., and Yang D. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J. Immunol. 174 (2005) 6257-6265
29. 7 and phospholipids signalling: the search of the "missing link" in epithelial cells. Cell. Signal. 18 (2006) 2098-2104
30. Pfeiffer Z.A., Guerra A.N., Hill L.M., Gavala M.L., Prabhu U., Aga M., Hall D.J., and Bertics P.J. Nucleotide receptor signaling in murine macrophages is linked to reactive oxygen species generation. Free Radic. Biol. Med. 42 (2007) 1506-1516
31. Murakami M., Lopez-Garcia B., Braff M., Dorschner R.A., and Gallo R.L. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172 (2004) 3070-3077
32. Surprenant A.M., and North R.A. Signaling at Purinergic P2X Receptors. Annu. Rev. Physiol. 71 (2008) 333-359
33. Hu J.Y., Le Y., Gong W., Dunlop N.M., Gao J.L., Murphy P.M., and Wang J.M. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. J. Leukoc. Biol. 70 (2001) 155-161
34. Kang H.K., Lee H.Y., Kim M.K., Park K.S., Park Y.M., Kwak J.Y., and Bae Y.S. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2. J. Immunol. 175 (2005) 685-692
35. Devosse T., Guillabert A., D'Haene N., Berton A., De Nadai P., Noel S., Brait M., Franssen J.D., Sozzani S., Salmon I., and Parmentier M. Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils. J. Immunol. 182 (2009) 4974-4984
36. 7 receptor and macrophage function. Purinergic Signal 5 (2009) 189-195
37. 7 receptor in a structure-dependent manner. J. Biol. Chem. 283 (2008) 30471-30481
38. Yu K., Park K., Kang S.-W., Shin S.Y., Hahm K.-S., and Kim Y. Solution structure of a cathelicidin-derived antimicrobial peptide, CRAMP as determined by NMR spectroscopy. J. Peptide Res. 60 (2002) 1-9
39. Pestonjamasp V.K., Huttner K.H., and Gallo R.L. Processing site and gene structure for the murine antimicrobial peptide CRAMP. Peptides 22 (2001) 1643-1650
40. Wang G., Li X., and Wang Z. APD2: the updated antimicrobial peptide data base and its application in peptide design. Nucleic Acids Res 37 (2009) D933-D937
41. 7 receptor. FEBS Lett. 13 (1998) 26-30
42. Young M.T., Pelegrin P., and Surprenant A. Surprenant, Amino acid residues in the P2X7 receptor that mediate differential sensitivity to ATP and BzATP. Mol Pharmacol. 71 (2007) 92-100